These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 29247745

  • 1. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF, Wang M, Xu JL.
    Life Sci; 2018 Feb 01; 194():1-6. PubMed ID: 29247745
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
    Wang B, He YJ, Tian YX, Yang RN, Zhu YR, Qiu H.
    Asian Pac J Cancer Prev; 2014 Feb 01; 15(22):9611-4. PubMed ID: 25520076
    [Abstract] [Full Text] [Related]

  • 3. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    Zhang L, Liu D, Li L, Pu D, Zhou P, Jing Y, Yu H, Wang Y, Zhu Y, He Y, Li Y, Zhao S, Qiu Z, Li W.
    BMC Cancer; 2017 Feb 02; 17(1):96. PubMed ID: 28152979
    [Abstract] [Full Text] [Related]

  • 4. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
    Bai Y, Shen W, Zhu M, Zhang L, Wei Y, Tang H, Zhao J.
    J Cell Biochem; 2019 Jan 02; 120(1):105-114. PubMed ID: 30216488
    [Abstract] [Full Text] [Related]

  • 5. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
    Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F.
    J Transl Med; 2019 Mar 08; 17(1):74. PubMed ID: 30849967
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer.
    Wang H, Zhang X, Liu X, Liu K, Li Y, Xu H.
    J Cancer Res Ther; 2016 Mar 08; 12(1):355-8. PubMed ID: 27072263
    [Abstract] [Full Text] [Related]

  • 7. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L, Xie XW, Wang HY, Ma LY, Wen ZG.
    Asian Pac J Cancer Prev; 2015 Mar 08; 16(12):4891-4. PubMed ID: 26163610
    [Abstract] [Full Text] [Related]

  • 8. [Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].
    Liang P, Li J.
    Zhongguo Fei Ai Za Zhi; 2016 Oct 20; 19(10):641-647. PubMed ID: 27760591
    [Abstract] [Full Text] [Related]

  • 9. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
    Wang Y, Wang Z, Ding Y, Sun F, Ding X.
    Asian Pac J Cancer Prev; 2019 Aug 01; 20(8):2405-2407. PubMed ID: 31450913
    [Abstract] [Full Text] [Related]

  • 10. Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.
    Yang-Chun F, Min F, Di Z, Yan-Chun H.
    Medicine (Baltimore); 2016 May 01; 95(18):e3568. PubMed ID: 27149479
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer.
    Sun M, Song J, Zhou Z, Zhu R, Jin H, Ji Y, Lu Q, Ju H.
    Dis Markers; 2016 May 01; 2016():3823121. PubMed ID: 26880855
    [Abstract] [Full Text] [Related]

  • 12. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F, Li WM, Wang DM, Gao SS, Bao Y, Chen WB, Liu D.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep 01; 39(5):832-5. PubMed ID: 19024326
    [Abstract] [Full Text] [Related]

  • 13. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
    Ni J, Guo Z, Zhang L.
    Zhonghua Nei Ke Za Zhi; 2016 Jan 01; 55(1):25-30. PubMed ID: 26796649
    [Abstract] [Full Text] [Related]

  • 14. Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers.
    Zhu K, Chen L, He C, Lang Y, Kong X, Qu C, Xu S.
    Dis Markers; 2020 Jan 01; 2020():6430459. PubMed ID: 32089756
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
    Ni LF, Liu XM.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct 18; 46(5):707-10. PubMed ID: 25331391
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis.
    Chu XY, Hou XB, Song WA, Xue ZQ, Wang B, Zhang LB.
    Cancer Biol Ther; 2011 Jun 15; 11(12):995-1000. PubMed ID: 21483235
    [Abstract] [Full Text] [Related]

  • 17. Biomarkers in the lung cancer diagnosis: a clinical perspective.
    Li X, Asmitananda T, Gao L, Gai D, Song Z, Zhang Y, Ren H, Yang T, Chen T, Chen M.
    Neoplasma; 2012 Jun 15; 59(5):500-7. PubMed ID: 22668014
    [Abstract] [Full Text] [Related]

  • 18. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
    Wang WJ, Tao Z, Gu W, Sun LH.
    Asian Pac J Cancer Prev; 2013 Jun 15; 14(7):4369-71. PubMed ID: 23992005
    [Abstract] [Full Text] [Related]

  • 19. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
    Yang Q, Zhang P, Wu R, Lu K, Zhou H.
    Dis Markers; 2018 Jun 15; 2018():2082840. PubMed ID: 30364165
    [Abstract] [Full Text] [Related]

  • 20. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
    Wang P, Piao Y, Zhang X, Li W, Hao X.
    Cancer Biomark; 2013 Jun 15; 13(2):123-30. PubMed ID: 23838141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.